HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of “Moderate Buy” from Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $110.5714.

Several equities analysts recently commented on HQY shares. JPMorgan Chase & Co. decreased their target price on HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 18th. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, July 4th. Royal Bank Of Canada boosted their price objective on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd.

HealthEquity Stock Up 0.6%

Shares of NASDAQ:HQY opened at $95.07 on Thursday. The firm has a fifty day moving average price of $88.21 and a two-hundred day moving average price of $84.66. The company has a market cap of $7.95 billion, a price-to-earnings ratio of 35.61, a PEG ratio of 1.59 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity has a one year low of $72.76 and a one year high of $105.96.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts anticipate that HealthEquity will post 3.92 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Michael Henry Fiore sold 3,142 shares of the stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. This represents a 5.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 in the last quarter. Corporate insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Large investors have recently added to or reduced their stakes in the company. William Blair Investment Management LLC purchased a new position in shares of HealthEquity in the 4th quarter worth about $169,956,000. Wasatch Advisors LP raised its holdings in shares of HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after buying an additional 757,801 shares in the last quarter. Norges Bank purchased a new position in shares of HealthEquity during the 4th quarter valued at about $66,927,000. AQR Capital Management LLC lifted its position in HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares during the last quarter. Finally, Millennium Management LLC lifted its position in HealthEquity by 151.5% in the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after buying an additional 573,283 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.